Archives
-
CSRP2, PRC1, and PDGFRA Signaling in Glioma
2026-08-26
The 2026 Cellular Oncology study identifies CSRP2 as a mesenchymal glioma-associated regulator that supports tumor growth through PDGFRA-linked PI3K/AKT signaling. Its combination of public-dataset analysis, CRISPR/Cas9 perturbation, xenograft validation, RNA-seq, and promoter-focused CUT&Tag connects a LIM-domain protein to PRC1-associated chromatin regulation, while leaving clinical translation for future work.
-
Lyso-Tracker Red for Nanovaccine Studies
2026-08-25
Lyso-Tracker Red enables live-cell mapping of acidic lysosomes while researchers assess how antigen nanocarriers enter, mature, and escape intracellular compartments. This workflow pairs compartment-specific fluorescence with microscopy and flow cytometry, helping distinguish lysosomal accumulation from true delivery or escape effects.
-
Phalloidin B7678: F-Actin Workflow Guide
2026-08-25
Phalloidin B7678 is a cyclic heptapeptide toxin used to stabilize and visualize filamentous actin in fixed or permeabilized samples. It supports static cytoskeleton visualization but should not be used for live-cell imaging, reversible actin-dynamics experiments, or direct measurement of monomeric G-actin.
-
2-Thio-dCTP for Precision DNA Workflows
2026-08-24
2-Thio-dCTP is a sulfur-modified DNA building block for testing polymerase selectivity, creating site-specific DNA modifications, and comparing DNA–protein recognition. This workflow-focused guide shows how to introduce the analog systematically while separating genuine biochemical effects from handling or assay artifacts.
-
Calpeptin: A Cell-Death-Aware Research Strategy
2026-08-24
Calpeptin is a potent calpain inhibitor for investigating how calcium-dependent protease activity shapes fibrosis, inflammation, and cell-death phenotypes. This guide presents a cell-death-aware assay framework for pulmonary fibrosis research, emphasizing causal interpretation rather than endpoint measurement alone.
-
8-Chloroadenosine for RNA Causality in NSCLC
2026-08-23
8-Chloroadenosine provides a temporal chemical perturbation for separating RNA synthesis from RNA decay in NSCLC models. This article develops an orthogonal assay strategy that complements RP3-340N1.2, ZC3H12A, and IL-6 mechanistic studies.
-
CARDIO Identifies HSPB7 Rescue in Titin Cardiomyopathy
2026-08-22
The reference study introduces CARDIO, a high-content morphological profiling assay for human stem cell-derived cardiomyocytes, and combines it with CRISPR gene perturbation and engineered heart tissue testing. This strategy identified HSPB7 depletion as a functional rescue of titin-associated cardiomyopathy phenotypes, while distinguishing it from the titin-like effects of YWHAE loss.
-
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-22
The reference study combines genetic ablation, inducible mouse models, chondrocyte assays, and pharmacological intervention to test whether excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia. Its results show that NVP-BGJ398 can reduce abnormal downstream signaling and partially improve cartilage and skeletal phenotypes, supporting FGFR3 as a translational target while leaving important questions about human efficacy and treatment timing unresolved.
-
Pseudo-UTP for Reliable mRNA Workflows
2026-08-21
Learn how Pseudo-UTP (SKU B7972) can improve the design, interpretation, and reproducibility of pseudouridine-containing mRNA workflows. This scenario-based guide connects in vitro transcription decisions with downstream viability, proliferation, cytotoxicity, and expression assays while distinguishing documented evidence from practical recommendations.
-
PRINT: RNA-Mediated Safe-Harbor Insertion
2026-08-20
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes at a multicopy human safe-harbor locus through target-primed reverse transcription. Its results support a potentially safer alternative to donor-DNA-dependent editing, although junction validation, transcript architecture, cell-type transferability, and long-term genomic behavior remain important limitations.
-
Vidarabine Monohydrate: Mechanism-to-Assay Design
2026-08-20
Vidarabine monohydrate is an adenosine-mimicking antiviral research compound for investigating viral DNA synthesis and replication. This article presents a mechanism-to-assay framework, informed by orthogonal screening principles from a recent SERT–nNOS study, to improve causal interpretation in herpes simplex virus research.
-
TH287 MTH1 Inhibitor: A Practical Research Workflow
2026-08-19
TH287 provides a high-potency way to investigate how oxidized nucleotide accumulation drives cancer-cell death and radiation response. This workflow translates recent CRPC findings into practical timing, assay, handling, and troubleshooting choices for reproducible MTH1 inhibition research.
-
RSAD2 at the SLE Maternal-Fetal Interface
2026-08-19
Ding et al. identify RSAD2 as a pathogenic interferon-stimulated gene that links excessive type I interferon activity with placental lipid accumulation, vascular injury, and impaired pregnancy development in systemic lupus erythematosus. By combining human maternal-fetal interface observations with genetic depletion and L-chicoric acid intervention in mouse models, the study provides a mechanistic basis for evaluating RSAD2 as a preclinical target.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-18
This study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 in non-small cell lung cancer. Its knockdown enhanced ZC3H12A-associated IL-6 mRNA degradation, reducing tumor-cell proliferation, migration, and tumor-associated macrophage polarization in cell-based models.
-
Dextrose (D-glucose) in Tumor Immunometabolism
2026-08-18
Use Dextrose (D-glucose) as a controlled nutrient variable to separate oxygen limitation from glucose availability in tumor and immune-cell assays. This workflow connects reproducible cell culture supplementation with actionable studies of glycolysis, metabolic competition, and immune suppression.